{"id":809818,"date":"2025-02-06T08:08:04","date_gmt":"2025-02-06T13:08:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/"},"modified":"2025-02-06T08:08:04","modified_gmt":"2025-02-06T13:08:04","slug":"krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/","title":{"rendered":"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025"},"content":{"rendered":"
\n

PITTSBURGH, Feb. 06, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc.<\/u><\/a> (the \u201cCompany\u201d) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its fourth quarter and full year 2024 financial results on Wednesday, February 19, 2025, prior to the open of U.S. markets.<\/p>\n

The Company\u2019s management will also host a conference call and webcast at 8:30 am ET on Wednesday, February 19, 2025, to discuss the financial results and provide a business update.<\/p>\n

Investors and the general public can access the live webcast at: https:\/\/www.webcaster4.com\/Webcast\/Page\/3018\/51976<\/u><\/a>.<\/p>\n

For those unable to listen to the live webcast, a replay will be available for 30 days on the Investors section of the Company\u2019s website at\u00a0www.krystalbio.com<\/u><\/a>.<\/p>\n

\n About Krystal Biotech, Inc.<\/strong>
\n
Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK\u00ae is the Company\u2019s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http:\/\/www.krystalbio.com<\/u><\/a>, and follow @KrystalBiotech on LinkedIn<\/u><\/a> and X<\/u><\/a> (formerly Twitter).<\/p>\n

\n CONTACT<\/strong>
\n
\n Investors and Media:<\/strong>
\n
St\u00e9phane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com<\/u><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PITTSBURGH, Feb. 06, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the \u201cCompany\u201d) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its fourth quarter and full year 2024 financial results on Wednesday, February 19, 2025, prior to the open of U.S. markets. The Company\u2019s management will also host a conference call and webcast at 8:30 am ET on Wednesday, February 19, 2025, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https:\/\/www.webcaster4.com\/Webcast\/Page\/3018\/51976. For those unable to listen to the live webcast, a replay will be available for 30 days on the Investors section of the Company\u2019s website at\u00a0www.krystalbio.com. About Krystal Biotech, Inc. Krystal Biotech, Inc. … <\/p>\n

Continue reading “Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-809818","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nKrystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PITTSBURGH, Feb. 06, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the \u201cCompany\u201d) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its fourth quarter and full year 2024 financial results on Wednesday, February 19, 2025, prior to the open of U.S. markets. The Company\u2019s management will also host a conference call and webcast at 8:30 am ET on Wednesday, February 19, 2025, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https:\/\/www.webcaster4.com\/Webcast\/Page\/3018\/51976. For those unable to listen to the live webcast, a replay will be available for 30 days on the Investors section of the Company\u2019s website at\u00a0www.krystalbio.com. About Krystal Biotech, Inc. Krystal Biotech, Inc. … Continue reading "Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-06T13:08:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025\",\"datePublished\":\"2025-02-06T13:08:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/\"},\"wordCount\":247,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/\",\"name\":\"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=\",\"datePublished\":\"2025-02-06T13:08:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/","og_locale":"en_US","og_type":"article","og_title":"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - Market Newsdesk","og_description":"PITTSBURGH, Feb. 06, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the \u201cCompany\u201d) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its fourth quarter and full year 2024 financial results on Wednesday, February 19, 2025, prior to the open of U.S. markets. The Company\u2019s management will also host a conference call and webcast at 8:30 am ET on Wednesday, February 19, 2025, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https:\/\/www.webcaster4.com\/Webcast\/Page\/3018\/51976. For those unable to listen to the live webcast, a replay will be available for 30 days on the Investors section of the Company\u2019s website at\u00a0www.krystalbio.com. About Krystal Biotech, Inc. Krystal Biotech, Inc. … Continue reading \"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-06T13:08:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025","datePublished":"2025-02-06T13:08:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/"},"wordCount":247,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/","name":"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=","datePublished":"2025-02-06T13:08:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzUxNCM2NzM3MTYwIzIwOTE5Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-19-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=809818"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809818\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=809818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=809818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=809818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}